[1] LARS PLATE. Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation.[J]. ACS Applied Nano Materials, 2016. DOI:
10.7554/elife.15550[2] RYAN PAXMAN. Pharmacologic ATF6 activating compounds are metabolically activated to selectively modify endoplasmic reticulum proteins.[J]. eLife, 2018. DOI:
10.7554/elife.37168[3] HEIKE KROEGER. The unfolded protein response regulator ATF6 promotes mesodermal differentiation[J]. Science Signaling, 2018, 11 517. DOI:
10.1126/scisignal.aan5785[4] ERIK BLACKWOOD . Pharmacologic ATF6 Activation Confers Global Protection in Widespread Disease Models by Reprogramming Cellular Proteostasis[J]. Journal of molecular and cellular cardiology, 2018, 124: Page 97. DOI:
10.1016/j.yjmcc.2018.07.047[5] KATHERINE M ALMASY. Small-molecule endoplasmic reticulum proteostasis regulator acts as a broad-spectrum inhibitor of dengue and Zika virus infections.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2021. DOI:
10.1073/pnas.2012209118[6] JESSICA D. ROSARDA. Metabolically Activated Proteostasis Regulators Protect against Glutamate Toxicity by Activating NRF2[J]. ACS Chemical Biology, 2021, 16 1: 2852-2863. DOI:
10.1101/2021.06.29.450364